CITIUS ONCOLOGY, INC. 8-K

What Happened
Citius Oncology, Inc. (CTOR) announced on June 1, 2026 that it issued a press release reporting the presentation of clinical data at the Annual Meeting of the American Society of Clinical Oncology (ASCO). The company filed a Current Report on Form 8-K (Item 8.01) to furnish the press release as Exhibit 99.1.

Key Details

• Press release date: June 1, 2026.
• Event: Presentation of clinical data at the Annual Meeting of the American Society of Clinical Oncology (ASCO).
• SEC filing: Form 8-K filed to disclose the press release; press release furnished as Exhibit 99.1.
• No financial results or executive changes were reported in this filing (the filing is limited to Other Events and exhibits).

Why It Matters
Clinical data presentations at ASCO are a primary way oncology companies share trial results and program updates with clinicians and investors. This 8-K informs investors that Citius Oncology is publicly disclosing such clinical data and timing of that disclosure. Investors tracking the company’s pipeline, clinical progress, or upcoming catalysts should review the furnished press release (Exhibit 99.1) for the specific data and context.